KIMIA Noavaran Daroui

Kimia Noavaran Darou (KND) is a specialized pharmaceutical company based in Iran that focuses on the research, development, and manufacturing of high-tech medicinal products. The company primarily operates in the fields of oncology, hematology, and pulmonology, with a strong emphasis on producing advanced generic versions of complex small molecule inhibitors. KND's portfolio includes several tyrosine kinase inhibitors used to treat various forms of cancer and chronic lung diseases. The company maintains state-of-the-art manufacturing facilities that comply with international GMP standards to ensure high-quality therapeutic options. By leveraging local expertise and innovation, KND aims to improve patient access to life-saving treatments within the regional healthcare market.